Used as a cytotoxic payload in antibody-drug conjugates (ADCs) for targeted cancer therapy. It inhibits cell division by blocking microtubule polymerization, leading to apoptosis in tumor cells. Due to its high potency, it is effective at low concentrations when delivered selectively to cancer cells via monoclonal antibodies. Commonly employed in treatments for hematological malignancies and solid tumors.